Dahlöf B, Andersson O K
Department of Medicine, Ostra Hospital, Gothenburg, Sweden.
J Hum Hypertens. 1995 Jul;9 Suppl 2:S43-7.
The current failure of antihypertensive therapy to control BP in many hypertensive patients highlights the need for new treatment strategies. Ideally, these new strategies should provide reliable, effective 24 h BP control in all types of patients with a convenient, well-tolerated regimen. Logimax, an extended-release tablet containing felodipine and metoprolol, has been developed, which provides more effective control of BP in a wider range of patients than either component as monotherapy, without compromising tolerability. This combination increases the likelihood of achieving target BP and is therefore likely to provide further reductions in cardiovascular risk.
目前，许多高血压患者的降压治疗未能有效控制血压，这凸显了新治疗策略的必要性。理想情况下，这些新策略应能以方便且耐受性良好的方案，为所有类型的患者提供可靠、有效的24小时血压控制。Logimax是一种含有非洛地平和美托洛尔的缓释片，与单一成分的单药治疗相比，它能在更广泛的患者中更有效地控制血压，且不影响耐受性。这种联合用药增加了实现目标血压的可能性，因此可能进一步降低心血管风险。
